Dermatomyositis-lupus overlap syndrome complicated with cardiomyopathy after SARS-CoV-2 infection: A new potential trigger for musculoskeletal autoimmune disease development

10Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

COVID-19 should be considered as a new triggering factor for autoimmune disorders like DM-lupus overlap syndrome. We recommend that patients presenting with dermatomyositis during this pandemic be screened for COVID-19.

Cite

CITATION STYLE

APA

Shahidi Dadras, M., Rakhshan, A., Ahmadzadeh, A., Hosseini, S. A., Diab, R., Safari Giv, T., & Abdollahimajd, F. (2021). Dermatomyositis-lupus overlap syndrome complicated with cardiomyopathy after SARS-CoV-2 infection: A new potential trigger for musculoskeletal autoimmune disease development. Clinical Case Reports, 9(10). https://doi.org/10.1002/ccr3.4931

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free